OÜ BioChemtec

11229119

General info

Name

OÜ BioChemtec

Registry code

11229119

VAT number

EE101045236

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

27.02.2006 (20)

Financial year

01.01-31.12

Capital

8 500.00 €

Activity

72111 - Research and experimental development on biotechnology

Revenue

0 €

Profit

-3 828 €

Profit margin

-

Gross salary

-

Equity

225 599 €

Employees

0

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

-2%

Return on assets

-1%

Related parties

Owner Representative Beneficial owner

Toomas Tamm

- - Indirect ownership

Andres Kund

- Board member Member of a higher management body, i.e. board member or supervisory board member

Markku Kemppinen

- Board member Member of a higher management body, i.e. board member or supervisory board member

Andrias Kund

60% - 5 100.00 EUR - Direct ownership

Osaühing T.R. TAMME AUTO

10020438

40% - 3 400.00 EUR - -

Financial info

2019
09.11.2020
2020
30.06.2021
2021
30.06.2022
2022
30.06.2023
2023
30.06.2024
2024
30.06.2025
Total Revenue 900 € 0 € 0 € 0 € 215 020 € 0 €
Net profit (loss) for the period -26 737 € -13 471 € -5 998 € -4 118 € 211 361 € -3 828 €
Profit Margin -2971% - - - 98% -
Current Assets 72 185 € 81 601 € 80 888 € 80 526 € 291 632 € 291 676 €
Fixed Assets - - - - - -
Total Assets 72 185 € 81 601 € 80 888 € 80 526 € 291 632 € 291 676 €
Current Liabilities 30 531 € 53 418 € 58 704 € 62 460 € 62 205 € 66 077 €
Non Current Liabilities 0 € 0 € 0 € 0 € 0 € -
Total Liabilities - - - - - -
Share Capital - - - - - -
Equity 41 654 € 28 183 € 22 184 € 18 066 € 229 427 € 225 599 €
Employees 1 0 0 0 0 0

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2025 Q4 0 € - - -
2025 Q3 0 € - - -
2025 Q2 0 € - - -
2025 Q1 0 € - - -
2024 Q4 0 € - - -
2024 Q3 0 € - - -
2024 Q2 0 € - - -
2024 Q1 213 020 € 368 € 0 € -
2023 Q4 2 000 € 375 € 0 € -
2023 Q3 0 € - - -
2023 Q2 0 € - - -
2023 Q1 0 € - - -
2022 Q4 0 € - - -
2022 Q3 0 € - - -
2022 Q2 0 € - - -
2022 Q1 0 € 792 € 807 € -